Zacks Investment Research Downgrades Addus Homecare (ADUS) to Strong Sell  Donna Armstrong | Aug 17th, 2018
Zacks Investment Research cut shares of Addus Homecare (NASDAQ:ADUS) from a hold rating to a strong sell rating in a research note published on Monday morning.
According to Zacks, "ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. " Get Addus Homecare alerts:
Other equities analysts have also recently issued research reports about the company. BidaskClub cut Addus Homecare from a strong-buy rating to a buy rating in a research note on Friday, August 10th. ValuEngine upgraded Addus Homecare from a hold rating to a buy rating in a research note on Wednesday, May 2nd. Robert W. Baird restated a hold rating and set a $65.00 target price on shares of Addus Homecare in a research note on Wednesday, August 8th. Oppenheimer boosted their target price on Addus Homecare from $50.00 to $72.00 and gave the stock an outperform rating in a research note on Wednesday, August 8th. Finally, Stephens boosted their target price on Addus Homecare from $67.00 to $75.00 and gave the stock an overweight rating in a research note on Tuesday, August 7th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $68.00.
Shares of ADUS opened at $58.30 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.09 and a quick ratio of 3.09. The stock has a market capitalization of $750.39 million, a PE ratio of 40.21, a P/E/G ratio of 2.63 and a beta of -0.39. Addus Homecare has a 1 year low of $30.95 and a 1 year high of $71.78.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings data on Tuesday, August 7th. The company reported $0.50 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.51 by ($0.01). The company had revenue of $131.24 million during the quarter, compared to analysts' expectations of $127.81 million. Addus Homecare had a net margin of 3.43% and a return on equity of 10.45%. sell-side analysts expect that Addus Homecare will post 1.63 EPS for the current year.
A number of hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its stake in Addus Homecare by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 913,787 shares of the company's stock worth $52,317,000 after purchasing an additional 15,487 shares during the last quarter. BlackRock Inc. lifted its stake in Addus Homecare by 31.9% during the second quarter. BlackRock Inc. now owns 585,281 shares of the company's stock worth $33,505,000 after purchasing an additional 141,597 shares during the last quarter. OppenheimerFunds Inc. lifted its stake in Addus Homecare by 2.7% during the second quarter. OppenheimerFunds Inc. now owns 224,079 shares of the company's stock worth $12,828,000 after purchasing an additional 5,795 shares during the last quarter. Renaissance Technologies LLC lifted its stake in Addus Homecare by 191.1% during the second quarter. Renaissance Technologies LLC now owns 183,700 shares of the company's stock worth $10,517,000 after purchasing an additional 120,600 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in Addus Homecare by 3.9% during the second quarter. Russell Investments Group Ltd. now owns 95,864 shares of the company's stock worth $5,497,000 after purchasing an additional 3,616 shares during the last quarter. Hedge funds and other institutional investors own 91.50% of the company's stock.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Get a free copy of the Zacks research report on Addus Homecare (ADUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com Addus Homecare Addus Homecar